Lexington Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 27, 2019 at 02:00 pm EDT
Lexington Biosciences, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced net loss was CAD 126,858 compared to CAD 781,567 a year ago. Basic earnings per share from continuing operations was CAD 0.05 compared to CAD 0.21 a year ago. For the half year, net loss was CAD 330,326 compared to CAD 1.525 million a year ago. Basic earnings per share from continuing operations was CAD 0.09 compared to CAD 0.4 a year ago.